IGC Pharma (IGC) Goodwill & Intangibles (2011 - 2026)
IGC Pharma (IGC) reported Goodwill & Intangibles of $4.8 million for Q1 2026, up 758.33% year-over-year from $564000.0 in Q1 2025, and up 600.58% quarter-over-quarter from $691000.0 in Q4 2025.
IGC Pharma (IGC) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Goodwill & Intangibles data on file, last reported at $4.8 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $4.8 million, up 758.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 758.33% YoY), and the FY2026 annual result was $4.8 million, up 758.33% from the prior year.
- Goodwill & Intangibles advanced to $4.8 million in Q1 2026 per IGC's latest filing, from $691000.0 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $4.8 million in Q1 2026 and troughed at $271000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $691000.0 in 2025 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles slumped 81.48% in 2025, then soared 758.33% in 2026.
- A 5-year view of Goodwill & Intangibles shows it stood at $476000.0 in 2022, then increased by 27.52% to $607000.0 in 2023, then dropped by 5.93% to $571000.0 in 2024, then increased by 21.02% to $691000.0 in 2025, then jumped by 600.58% to $4.8 million in 2026.
- Business Quant data shows IGC's Goodwill & Intangibles at $4.8 million in Q1 2026, $691000.0 in Q4 2025, and $334000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | IGC Pharma | 28.11 Mn | 27.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.84 Mn |
| Dec 31, 2025 | 691,000.00 |
| Sep 30, 2025 | 334,000.00 |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 564,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 927,000.00 |
| Dec 31, 2023 | 607,000.00 |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 549,000.00 |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 476,000.00 |
| Sep 30, 2022 | 952,000.00 |
| Jun 30, 2022 | 444,000.00 |
| Mar 31, 2022 | 271,000.00 |
| Dec 31, 2021 | 152,000.00 |
| Sep 30, 2021 | 272,000.00 |
| Jun 30, 2021 | 221,000.00 |